Showing results (711-720 of 792) with videos related to
Sort By:
Pageof 80
Blood|June 12, 2010
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisVikas Gupta, Martin S Tallman, Wensheng He, et al.Haematologica|September 18, 2012
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation ResearchArmand Keating, Gisela DaSilva, Waleska S Pérez, et al.Gastrointestinal Endoscopy|March 29, 2023
Same-session double EUS-guided bypass versus surgical gastroenterostomy and hepaticojejunostomy: an international multicenter comparisonMichiel Bronswijk, Giuseppe Vanella, Roy L J van Wanrooij, et al.Blood Advances|February 12, 2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donorsMichael R Grunwald, Mei-Jie Zhang, Hany Elmariah, et al.British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2010
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemiaRoland Chu, Ruta Brazauskas, Fangyu Kan, et al.Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2024
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY StudiesStacie Hudgens, Srdan Verstovsek, Lysbeth Floden, et al.Hemasphere|October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyRuben A Mesa, Claire Harrison, Jeanne M Palmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.Pageof 80